↓ Skip to main content

Heart Failure

Overview of attention for book
Cover of 'Heart Failure'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 13 Direct Myosin Activation by Omecamtiv Mecarbil for Heart Failure with Reduced Ejection Fraction
  3. Altmetric Badge
    Chapter 23 Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications
  4. Altmetric Badge
    Chapter 24 Heart Failure Guidelines on Pharmacotherapy
  5. Altmetric Badge
    Chapter 25 Role of Hyperkalemia in Heart Failure and the Therapeutic Use of Potassium Binders
  6. Altmetric Badge
    Chapter 27 Comorbidities in Heart Failure
  7. Altmetric Badge
    Chapter 28 Vasopressin and Vasopressin Antagonists in Heart Failure
  8. Altmetric Badge
    Chapter 30 Iron Deficiency Treatment in Patients with Heart Failure
  9. Altmetric Badge
    Chapter 31 Cardiac Myosin Activation with Gene Therapy Produces Sustained Inotropic Effects and May Treat Heart Failure with Reduced Ejection Fraction
  10. Altmetric Badge
    Chapter 55 Ivabradine.
  11. Altmetric Badge
    Chapter 56 Wnt Signaling in Cardiac Remodeling and Heart Failure
  12. Altmetric Badge
    Chapter 74 Epidemiology of Heart Failure
  13. Altmetric Badge
    Chapter 75 Clinical Trial Design, Endpoints, and Regulatory Requirements
  14. Altmetric Badge
    Chapter 76 Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside
  15. Altmetric Badge
    Chapter 77 Sacubitril/Valsartan (LCZ696) in Heart Failure
  16. Altmetric Badge
    Chapter 80 Platelet-Derived Growth Factor in Heart Failure
  17. Altmetric Badge
    Chapter 81 Gene Therapy in Heart Failure
  18. Altmetric Badge
    Chapter 82 Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease
  19. Altmetric Badge
    Chapter 83 Partial Adenosine A1 Agonist in Heart Failure
  20. Altmetric Badge
    Chapter 86 Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction
  21. Altmetric Badge
    Chapter 88 New and Emerging Therapies and Targets: Beta-3 Agonists
  22. Altmetric Badge
    Chapter 99 Noncoding RNAs in Heart Failure
  23. Altmetric Badge
    Chapter 100 Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure
  24. Altmetric Badge
    Chapter 101 The Three-Decade Long Journey in Heart Failure Drug Development
  25. Altmetric Badge
    Chapter 123 Mitochondrial Therapies in Heart Failure
  26. Altmetric Badge
    Chapter 126 Anticoagulation Therapy and NOACs in Heart Failure
Attention for Chapter 56: Wnt Signaling in Cardiac Remodeling and Heart Failure
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Wnt Signaling in Cardiac Remodeling and Heart Failure
Chapter number 56
Book title
Heart Failure
Published in
Handbook of experimental pharmacology, November 2016
DOI 10.1007/164_2016_56
Pubmed ID
Book ISBNs
978-3-31-959658-7, 978-3-31-959659-4
Authors

Stylianidis, Vasili, Hermans, Kevin C M, Blankesteijn, W Matthijs, Vasili Stylianidis, Kevin C. M. Hermans, W. Matthijs Blankesteijn

Abstract

Wnt signaling plays an essential role during development, but is also activated in diseases as diverse as neurodegeneration, osteoporosis, and cancer. Accumulating evidence demonstrates that Wnt signaling is also activated during cardiac remodeling and heart failure. In this chapter, we will provide a brief overview of Wnt signaling in all its complexity. Then we will discuss the evidence for its involvement in the development of cardiac hypertrophy, the wound healing after myocardial infarction (MI) and heart failure. Finally, we will provide an overview of the drugs that are available to target Wnt signaling at different levels of the signaling cascade and the results of these pharmacological interventions in cardiac disease.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 29%
Student > Doctoral Student 4 13%
Student > Ph. D. Student 3 10%
Lecturer 2 6%
Student > Master 2 6%
Other 4 13%
Unknown 7 23%
Readers by discipline Count As %
Medicine and Dentistry 10 32%
Biochemistry, Genetics and Molecular Biology 9 29%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Engineering 1 3%
Unknown 10 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2017.
All research outputs
#18,510,888
of 22,931,367 outputs
Outputs from Handbook of experimental pharmacology
#503
of 646 outputs
Outputs of similar age
#234,026
of 308,796 outputs
Outputs of similar age from Handbook of experimental pharmacology
#12
of 19 outputs
Altmetric has tracked 22,931,367 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 646 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 308,796 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.